Economic Strategies for Health Content


December 3, 2008 | In a video from Health Content 08 (November 12-13, Philadelphia), the managing director of Berkery Noyes investment bank, Thomas O’Connor, discusses how the economic downturn may impact investment in health content and technology companies. He also talks about how companies can tie their content to the bottom line. Berkery Noyes

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Applications of LIMS for Enhanced Productivity in Translational Discovery Research
Sponsored by Ocimum
Translational research can improve the effectiveness of drug research and target discovery pursuits. However, managing the massive amounts of data has posed enormous challenges for –omics and biorepository labs. This white paper discusses the latest developments in translational research and describes how an adaptive data infrastructure and a flexible Lab Information Management Solution (LIMS) framework can be pivotal for successful Translational Research.


Clinical Information Fusion for R&D;
Sponsored by SAIC

Clinical Information Fusion: Introduction

Over the years, Pharma R&D;’s well established functional specific systems created information Silos that provide inaccurate, out-of-date, and incomplete data and reports. The results are missed opportunities and delays that ultimately cause missed deadlines of final drug submissions, costing drug companies millions in lost revenues.

The Clinical Information Fusion white paper discusses how these information silos can be broken to provide on-demand up-to-date information supporting immediate business needs, utilizing existing technology investments, and reducing future implementation and maintenance costs.



Adobe® LiveCycle® ES
Deploying Adobe Technology to Automate Electronic Submissions
Sponsored by Adobe
Discover how to:
  • Help reduce the cost of bringing products to market
  • Improve document collaboration across your organization
  • Satisfy global regulatory requirements, stockholder expectations, and customer demands
  • Improve data capture, information assurance, document output, process management, and content services
  • Gain a competitive advantage, get immediate ROI


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Related Resources & Products

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
Post-Approval Drug Safety Strategies
Executive Summit on Strategy and Innovation
Executive Summit on Strategy and Innovation



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].